ESTIMATING THE RISK OF SEVERE RETINOPATHY OF PREMATURITY
评估严重早产儿视网膜病变的风险
基本信息
- 批准号:6384864
- 负责人:
- 金额:$ 7.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-05-01 至 2003-04-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Retinopathy of prematurity (ROP) is a fibrovascular proliferative disease of the immature retina and an important cause of visual impairment and blindness in premature infants. The results of treating severe (threshold) ROP are not always successful. There is growing interest in preventing severe ROP, as is apparent from proposals to study earlier interventions in infants deemed to be at risk for threshold ROP. Accurate earlier identification of infants at greatest risk for severe ROP is essential to permit aggressive early intervention trials, as well as to avoid exposing lower-risk infants unnecessarily to experimental or clinical intervention. A series of ROP risk models were developed based on data from the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (CRYO ROP), but these reflect infants and care practices of 1986-1987. Development of ROP risk models on contemporary premature infants which include new predictive factors should improve earlier identification of infants at risk for severe ROP. We propose to test the hypothesis that a contemporary ROP risk model which incorporates measures of illness severity, sequential scoring of ophthalmic findings, gestational age, and predictive demographic variables will improve estimation of an individual's risk of severe ROP compared to the CRYO ROP risk model. This will be accomplished through secondary analyses of a newly merged database (SNAP ROP database) from two existing research data sets which are the result of support by the NEI (ROP database) and AHCPR (illness severity SNAP database). The integration of these two data sets into a singularly rich, research quality database (SNAP ROP) presents an extraordinary opportunity to identify new physiologic-based, illness severity determinants of ROP and to develop contemporary ROP risk models for predicting severe (threshold) ROP. We will validate the illness severity ROP risk models (SNAP ROP risk models) on an independent neonatal population similar to the derivation cohort, and compare the performance of the SNAP ROP risk model with the CRYO ROP risk model for predicting threshold ROP (using CRYO ROP threshold definition) on a contemporary, neonatal population.
早产儿视网膜病变(Retinopathy of prematurity, ROP)是一种发生在未成熟视网膜的纤维血管增生性疾病,是导致早产儿视力损害和失明的重要原因。治疗严重(阈值)ROP的结果并不总是成功的。人们对预防严重的ROP越来越感兴趣,这一点从研究早期干预被认为有阈值ROP风险的婴儿的建议中可以明显看出。准确早期识别严重ROP风险最大的婴儿对于进行积极的早期干预试验以及避免将低风险婴儿不必要地暴露于实验或临床干预至关重要。基于早产儿视网膜病变冷冻治疗多中心试验(CRYO ROP)的数据,建立了一系列ROP风险模型,但这些模型反映了1986-1987年的婴儿和护理实践。包括新的预测因素的当代早产儿ROP风险模型的发展将有助于早期识别有严重ROP风险的婴儿。与CRYO ROP风险模型相比,我们建议验证一个包含疾病严重程度、眼科检查结果顺序评分、胎龄和预测人口变量的当代ROP风险模型,该模型将改善对个体严重ROP风险的估计。这将通过对来自NEI (ROP数据库)和AHCPR(疾病严重程度SNAP数据库)支持的两个现有研究数据集的新合并数据库(SNAP ROP数据库)的二次分析来完成。将这两个数据集整合到一个非常丰富的研究质量数据库(SNAP ROP)中,为确定新的基于生理的ROP疾病严重程度决定因素以及开发用于预测严重(阈值)ROP的当代ROP风险模型提供了一个非凡的机会。我们将在类似衍生队列的独立新生儿人群中验证疾病严重程度ROP风险模型(SNAP ROP风险模型),并比较SNAP ROP风险模型与CRYO ROP风险模型在当代新生儿人群中预测阈值ROP(使用CRYO ROP阈值定义)的性能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA Hamlet COLE其他文献
CYNTHIA Hamlet COLE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA Hamlet COLE', 18)}}的其他基金
Prophylaxis of Early Adrenal Insufficiency to Prevent Chronic Lung Disease
预防早期肾上腺功能不全以预防慢性肺病
- 批准号:
7040660 - 财政年份:2004
- 资助金额:
$ 7.9万 - 项目类别:
Extremely Low Gestational Age Neonates Study (ELGAN)
极低胎龄新生儿研究 (ELGAN)
- 批准号:
7040669 - 财政年份:2004
- 资助金额:
$ 7.9万 - 项目类别:
ESTIMATING THE RISK OF SEVERE RETINOPATHY OF PREMATURITY
评估严重早产儿视网膜病变的风险
- 批准号:
6085002 - 财政年份:2000
- 资助金额:
$ 7.9万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 7.9万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
- 批准号:
10762827 - 财政年份:2023
- 资助金额:
$ 7.9万 - 项目类别:














{{item.name}}会员




